Chemokines

Integrators of pain and inflammation

Fletcher White, Sonia K. Bhangoo, Richard J. Miller

Research output: Contribution to journalArticle

176 Citations (Scopus)

Abstract

Chronic (neuropathic) pain is one of the most widespread and intractable of human complaints, as well as being one of the most difficult syndromes to treat successfully with drugs or surgery. The development of new therapeutic approaches to the treatment of painful neuropathies requires a better understanding of the mechanisms that underlie the development of these chronic pain syndromes. It is clear that inflammatory responses often accompany the development of neuropathic pain, and here we discuss the idea that chemokines might be key to integrating the development of pain and inflammation and could furnish new leads in the search for effective analgesic agents for the treatment of painful neuropathies.

Original languageEnglish (US)
Pages (from-to)834-844
Number of pages11
JournalNature Reviews Drug Discovery
Volume4
Issue number10
DOIs
StatePublished - Oct 2005
Externally publishedYes

Fingerprint

Chemokines
Neuralgia
Inflammation
Pain
Chronic Pain
Analgesics
Therapeutics
Pharmaceutical Preparations
Painful Neuropathy

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Chemokines : Integrators of pain and inflammation. / White, Fletcher; Bhangoo, Sonia K.; Miller, Richard J.

In: Nature Reviews Drug Discovery, Vol. 4, No. 10, 10.2005, p. 834-844.

Research output: Contribution to journalArticle

White, Fletcher ; Bhangoo, Sonia K. ; Miller, Richard J. / Chemokines : Integrators of pain and inflammation. In: Nature Reviews Drug Discovery. 2005 ; Vol. 4, No. 10. pp. 834-844.
@article{7fd37de3039b492ab8da44beac05b73f,
title = "Chemokines: Integrators of pain and inflammation",
abstract = "Chronic (neuropathic) pain is one of the most widespread and intractable of human complaints, as well as being one of the most difficult syndromes to treat successfully with drugs or surgery. The development of new therapeutic approaches to the treatment of painful neuropathies requires a better understanding of the mechanisms that underlie the development of these chronic pain syndromes. It is clear that inflammatory responses often accompany the development of neuropathic pain, and here we discuss the idea that chemokines might be key to integrating the development of pain and inflammation and could furnish new leads in the search for effective analgesic agents for the treatment of painful neuropathies.",
author = "Fletcher White and Bhangoo, {Sonia K.} and Miller, {Richard J.}",
year = "2005",
month = "10",
doi = "10.1038/nrd1852",
language = "English (US)",
volume = "4",
pages = "834--844",
journal = "Nature Reviews Drug Discovery",
issn = "1474-1776",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Chemokines

T2 - Integrators of pain and inflammation

AU - White, Fletcher

AU - Bhangoo, Sonia K.

AU - Miller, Richard J.

PY - 2005/10

Y1 - 2005/10

N2 - Chronic (neuropathic) pain is one of the most widespread and intractable of human complaints, as well as being one of the most difficult syndromes to treat successfully with drugs or surgery. The development of new therapeutic approaches to the treatment of painful neuropathies requires a better understanding of the mechanisms that underlie the development of these chronic pain syndromes. It is clear that inflammatory responses often accompany the development of neuropathic pain, and here we discuss the idea that chemokines might be key to integrating the development of pain and inflammation and could furnish new leads in the search for effective analgesic agents for the treatment of painful neuropathies.

AB - Chronic (neuropathic) pain is one of the most widespread and intractable of human complaints, as well as being one of the most difficult syndromes to treat successfully with drugs or surgery. The development of new therapeutic approaches to the treatment of painful neuropathies requires a better understanding of the mechanisms that underlie the development of these chronic pain syndromes. It is clear that inflammatory responses often accompany the development of neuropathic pain, and here we discuss the idea that chemokines might be key to integrating the development of pain and inflammation and could furnish new leads in the search for effective analgesic agents for the treatment of painful neuropathies.

UR - http://www.scopus.com/inward/record.url?scp=27644510131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644510131&partnerID=8YFLogxK

U2 - 10.1038/nrd1852

DO - 10.1038/nrd1852

M3 - Article

VL - 4

SP - 834

EP - 844

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 10

ER -